<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39408576</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Lactoferrin Supplementation in Preventing and Protecting from SARS-CoV-2 Infection: Is There Any Role in General and Special Populations? An Updated Review of Literature.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10248</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms251910248</ELocationID><Abstract><AbstractText>At the beginning of the pandemic, SARS-CoV-2 infection represented a great medical burden worldwide, as targeted and effective therapeutic options were lacking. This resulted in the revival of existing molecules and the increasing popularity of over-the-counter nutritional supplements. Among the latter, lactoferrin has been investigated as an adjuvant in COVID-19 therapy with conflicting results, mainly depending on different study designs. Considering that lactoferrin is one of the main components of human breast milk with anti-microbial and anti-inflammatory activity, it is conceivable that such bioactive molecule could be effective in supporting anti-SARS-CoV-2 infection therapy, especially in infants and pregnant women, two subpopulations that have been poorly evaluated in the existing clinical trials. This narrative review is intended to offer insight into the existing literature on lactoferrin's biological functions and protective effects against COVID-19, with a special focus on pregnant women and their infants.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manzoni</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1340-3493</Identifier><AffiliationInfo><Affiliation>Department of Maternal, Neonatal and Infant Medicine, University Hospital "Degli Infermi", 13875 Ponderano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6868-036X</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sant'Anna Hospital, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Germano</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6951-3803</Identifier><AffiliationInfo><Affiliation>Department of Maternal, Neonatal and Infant Medicine, University Hospital "Degli Infermi", 13875 Ponderano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picone</LastName><ForeName>Simonetta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neonatology and Neonatal Intensive Care Unit, Policlinico Casilino, 00169 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masturzo</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5243-0940</Identifier><AffiliationInfo><Affiliation>Department of Maternal, Neonatal and Infant Medicine, University Hospital "Degli Infermi", 13875 Ponderano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sainaghi</LastName><ForeName>Pier Paolo</ForeName><Initials>PP</Initials><Identifier Source="ORCID">0000-0001-8322-9158</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine (DiMeT), Università del Piemonte Orientale (UPO), 28100 Novara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCAD (Interdisciplinary Research Center of Autoimmune Diseases), Università del Piemonte Orientale (UPO), 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sola</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7863-8192</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine (DiMeT), Università del Piemonte Orientale (UPO), 28100 Novara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Metabolic Research, IRCCS Istituto Auxologico Italiano, S. Giuseppe Hospital, 28824 Piancavallo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6174-7111</Identifier><AffiliationInfo><Affiliation>IRCAD (Interdisciplinary Research Center of Autoimmune Diseases), Università del Piemonte Orientale (UPO), 28100 Novara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences (DiSS), Università del Piemonte Orientale (UPO), 28100 Novara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="D007781">Lactoferrin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007781" MajorTopicYN="Y">Lactoferrin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008895" MajorTopicYN="N">Milk, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">infants</Keyword><Keyword MajorTopicYN="N">lactoferrin</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408576</ArticleId><ArticleId IdType="pmc">PMC11476995</ArticleId><ArticleId IdType="doi">10.3390/ijms251910248</ArticleId><ArticleId IdType="pii">ijms251910248</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bolat E., Eker F., Kaplan M., Duman H., Arslan A., Saritaş S., Şahutoğlu A.S., Karav S. Lactoferrin for COVID-19 prevention, treatment, and recovery. Front. Nutr. 2022;9:992733. doi: 10.3389/fnut.2022.992733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.992733</ArticleId><ArticleId IdType="pmc">PMC9676636</ArticleId><ArticleId IdType="pubmed">36419551</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 2022;20:270–284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutone A., Rosa L., Bonaccorsi Di Patti M.C., Iacovelli F., Conte M.P., Ianiro G., Romeo A., Campione E., Bianchi L., Valenti P., et al. Lactoferrin binding to SARS-CoV-2 spike glycoprotein blocks pseudoviral entry and relieves iron protein dysregulation in several in vitro models. Pharmaceutics. 2022;14:2111. doi: 10.3390/pharmaceutics14102111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14102111</ArticleId><ArticleId IdType="pmc">PMC9612385</ArticleId><ArticleId IdType="pubmed">36297546</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione E., Lanna C., Cosio T., Rosa L., Conte M.P., Iacovelli F., Romeo A., Falconi M., Del Vecchio C., Franchin E., et al. Lactoferrin against SARS-CoV-2: In vitro and in silico evidence. Front. Pharmacol. 2021;12:666600. doi: 10.3389/fphar.2021.666600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.666600</ArticleId><ArticleId IdType="pmc">PMC8242182</ArticleId><ArticleId IdType="pubmed">34220505</ArticleId></ArticleIdList></Reference><Reference><Citation>Triggle C.R., Bansal D., Ding H., Islam M.M., Farag E.A.B.A., Hadi H.A., Sultan A.A. A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic. Front. Immunol. 2021;12:631139. doi: 10.3389/fimmu.2021.631139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.631139</ArticleId><ArticleId IdType="pmc">PMC7952616</ArticleId><ArticleId IdType="pubmed">33717166</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradini E., Ventura P., Ageno W., Cogliati C.B., Muiesan M.L., Girelli D., Pirisi M., Gasbarrini A., Angeli P., Querini P.R., et al. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: Results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) Intern Emerg. Med. 2021;16:1005–1015. doi: 10.1007/s11739-021-02742-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02742-8</ArticleId><ArticleId IdType="pmc">PMC8065333</ArticleId><ArticleId IdType="pubmed">33893976</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki T. WHO ends the COVID-19 public health emergency. Lancet Respir. Med. 2023;11:588. doi: 10.1016/S2213-2600(23)00217-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00217-5</ArticleId><ArticleId IdType="pmc">PMC10219632</ArticleId><ArticleId IdType="pubmed">37247628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady D.K., Gurijala A.R., Huang L., Hussain A.A., Lingan A.L., Pembridge O.G., Ratangee B.A., Sealy T.T., Vallone K.T., Clements T.P. A guide to COVID-19 antiviral therapeutics: A summary and perspective of the antiviral weapons against SARS-CoV-2 infection. FEBS J. 2024;291:1632–1662. doi: 10.1111/febs.16662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16662</ArticleId><ArticleId IdType="pmc">PMC9874604</ArticleId><ArticleId IdType="pubmed">36266238</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns D.M., Dulko D., Griffiths J.K., Golan Y., Cohen T., Trinquart L., Price L.L., Beaulac K.R., Selker H.P. Efficacy of niclosamide vs placebo in SARS-CoV-2 respiratory viral clearance, viral shedding, and duration of symptoms among patients with mild to moderate COVID-19: A phase 2 randomized clinical trial. JAMA Netw. Open. 2022;5:e2144942. doi: 10.1001/jamanetworkopen.2021.44942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.44942</ArticleId><ArticleId IdType="pmc">PMC8829666</ArticleId><ArticleId IdType="pubmed">35138402</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirabelli C., Wotring J.W., Zhang C.J., McCarty S.M., Fursmidt R., Kadambi N.S., Amin A.T., O’Meara T.R., Pretto-Kernahan C.D., Spence J.R., et al. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc. Natl. Acad. Sci. USA. 2021;118:e2105815118. doi: 10.1073/pnas.2105815118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105815118</ArticleId><ArticleId IdType="pmc">PMC8433531</ArticleId><ArticleId IdType="pubmed">34413211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricordi C., Pacifici F., Lanzoni G., Palamara A.T., Garaci E., Della-Morte D. Dietary and protective factors to halt or mitigate progression of autoimmunity, COVID-19 and its associated metabolic diseases. Int. J. Mol. Sci. 2021;22:3134. doi: 10.3390/ijms22063134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063134</ArticleId><ArticleId IdType="pmc">PMC8003583</ArticleId><ArticleId IdType="pubmed">33808574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrityunjaya M., Pavithra V., Neelam R., Janhavi P., Halami P.M., Ravindra P.V. Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19. Front. Immunol. 2020;11:570122. doi: 10.3389/fimmu.2020.570122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.570122</ArticleId><ArticleId IdType="pmc">PMC7575721</ArticleId><ArticleId IdType="pubmed">33117359</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthon B.S., Williams L.M., Williams E.J., Wood L.G. Effect of lactoferrin supplementation on inflammation, immune function, and prevention of respiratory tract infections in humans: A systematic review and meta-analysis. Adv. Nutr. 2022;13:1799–1819. doi: 10.1093/advances/nmac047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmac047</ArticleId><ArticleId IdType="pmc">PMC9526865</ArticleId><ArticleId IdType="pubmed">35481594</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa L., Tripepi G., Naldi E., Aimati M., Santangeli S., Venditto F., Caldarelli M., Valenti P. Ambulatory COVID-19 patients treated with lactoferrin as a supplementary antiviral agent: A preliminary study. J. Clin. Med. 2021;10:4276. doi: 10.3390/jcm10184276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184276</ArticleId><ArticleId IdType="pmc">PMC8469309</ArticleId><ArticleId IdType="pubmed">34575388</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Ng T.B., Sun W.-Z. Lactoferrin as potential preventative and adjunct treatment for COVID-19. Int. J. Antimicrob. Agents. 2020;56:106118. doi: 10.1016/j.ijantimicag.2020.106118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106118</ArticleId><ArticleId IdType="pmc">PMC7390755</ArticleId><ArticleId IdType="pubmed">32738305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf M.F., Zubair D., Bashir M.N., Alagawany M., Ahmed S., Shah Q.A., Buzdar J.A., Arain M.A. Nutraceutical and health-promoting potential of lactoferrin, an iron-binding protein in human and animal: Current knowledge. Biol. Trace Elem. Res. 2024;202:56–72. doi: 10.1007/s12011-023-03658-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-023-03658-4</ArticleId><ArticleId IdType="pmc">PMC10104436</ArticleId><ArticleId IdType="pubmed">37059920</ArticleId></ArticleIdList></Reference><Reference><Citation>Conesa C., Bellés A., Grasa L., Sánchez L. The role of lactoferrin in intestinal health. Pharmaceutics. 2023;15:1569. doi: 10.3390/pharmaceutics15061569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics15061569</ArticleId><ArticleId IdType="pmc">PMC10304194</ArticleId><ArticleId IdType="pubmed">37376017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa T.J., Loli S., Mendoza K., Carcamo C., Bellomo S., Cam L., Castaneda A., Campos M., Jacobs J., Cossey V., et al. Effect of bovine lactoferrin on prevention of late-onset sepsis in infants &lt;1500 g: A pooled analysis of individual patient data from two randomized controlled trials. Biochem. Cell Biol. 2021;99:14–19. doi: 10.1139/bcb-2020-0046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/bcb-2020-0046</ArticleId><ArticleId IdType="pubmed">32931708</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarnow-Mordi W.O., Abdel-Latif M.E., Martin A., Pammi M., Robledo K., Manzoni P., Osborn D., Lui K., Keech A., Hague W., et al. The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): A multicentre, double-blind, randomised controlled trial. Lancet Child Adolesc. Health. 2020;4:444–454. doi: 10.1016/S2352-4642(20)30093-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30093-6</ArticleId><ArticleId IdType="pubmed">32407710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G., Gathwala G. Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: A randomized placebo-controlled clinical trial. J. Trop. Pediatr. 2015;61:370–376. doi: 10.1093/tropej/fmv044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmv044</ArticleId><ArticleId IdType="pubmed">26224129</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoni P., Meyer M., Stolfi I., Rinaldi M., Cattani S., Pugni L., Romeo M.G., Messner H., Decembrino L., Laforgia N., et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: A randomized clinical trial. Early Hum. Dev. 2014;90:S60–S65. doi: 10.1016/S0378-3782(14)70020-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-3782(14)70020-9</ArticleId><ArticleId IdType="pubmed">24709463</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoni P., Rinaldi M., Cattani S., Pugni L., Romeo M.G., Messner H., Stolfi I., Decembrino L., Laforgia N., Vagnarelli F., et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates. A randomized trial. JAMA. 2009;302:1421–1428. doi: 10.1001/jama.2009.1403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1403</ArticleId><ArticleId IdType="pubmed">19809023</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Feng G., Zhang X., Hu Q., Sun S., Sun J., Sun Y., Wang R., Zhang Y., Wang P., et al. The functional role of lactoferrin in intestine mucosal immune system and inflammatory bowel disease. Front. Nutr. 2021;8:759507. doi: 10.3389/fnut.2021.759507.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.759507</ArticleId><ArticleId IdType="pmc">PMC8655231</ArticleId><ArticleId IdType="pubmed">34901112</ArticleId></ArticleIdList></Reference><Reference><Citation>Presti S., Manti S., Parisi G.F., Papale M., Barbagallo I.A., Li Volti G., Leonardi S. Lactoferrin: Cytokine modulation and application in clinical practice. J. Clin. Med. 2021;10:5482. doi: 10.3390/jcm10235482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235482</ArticleId><ArticleId IdType="pmc">PMC8658270</ArticleId><ArticleId IdType="pubmed">34884183</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutone A., Ianiro G., Lepanto M.S., Rosa L., Valenti P., Bonaccorsi Di Patti M.C., Musci G. Lactoferrin in the prevention and treatment of intestinal inflammatory pathologies associated with colorectal cancer development. Cancers. 2020;12:3806. doi: 10.3390/cancers12123806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12123806</ArticleId><ArticleId IdType="pmc">PMC7766217</ArticleId><ArticleId IdType="pubmed">33348646</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A.S., Hasan S.S., Kow C.S., Merchant H.A. Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials. Clin. Nutr. ESPEN. 2021;45:26–32. doi: 10.1016/j.clnesp.2021.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.08.019</ArticleId><ArticleId IdType="pubmed">34620326</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda H., Wakabayashi H., Tanaka M., Yamauchi K., Sugita C., Yoshida H., Abe F., Sonoda T., Kurokawa M. Effects of lactoferrin on infectious diseases in Japanese summer: A randomized, double-blinded, placebo-controlled trial. J. Microbiol. Immunol. Infect. 2021;54:566–574. doi: 10.1016/j.jmii.2020.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.02.010</ArticleId><ArticleId IdType="pubmed">32151562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Zhang X., Xu T., Luo J., Luo Y., An P. Comparative effects between oral lactoferrin and ferrous sulfate supplementation on iron-deficiency anemia: A comprehensive review and meta-analysis of clinical trials. Nutrients. 2022;14:543. doi: 10.3390/nu14030543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14030543</ArticleId><ArticleId IdType="pmc">PMC8838920</ArticleId><ArticleId IdType="pubmed">35276902</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar O.M., Assem H., Ahmed D., Abd Elmaksoud M.S. Lactoferrin versus iron hydroxide polymaltose complex for the treatment of iron deficiency anemia in children with cerebral palsy: A randomized controlled trial. Eur. J. Pediatr. 2021;180:2609–2618. doi: 10.1007/s00431-021-04125-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04125-9</ArticleId><ArticleId IdType="pubmed">34101010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepanto M.S., Rosa L., Paesano R., Valenti P., Cutone A. Lactoferrin in aseptic and septic inflammation. Molecules. 2019;24:1323. doi: 10.3390/molecules24071323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24071323</ArticleId><ArticleId IdType="pmc">PMC6480387</ArticleId><ArticleId IdType="pubmed">30987256</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepanto M.S., Rosa L., Cutone A., Conte M.P., Paesano R., Valenti P. Efficacy of lactoferrin oral administration in the treatment of anemia and anemia of inflammation in pregnant and non-pregnant women: An interventional study. Front. Immunol. 2018;9:2123. doi: 10.3389/fimmu.2018.02123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02123</ArticleId><ArticleId IdType="pmc">PMC6160582</ArticleId><ArticleId IdType="pubmed">30298070</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Ren Y., Lu Q., Wang K., Wu Y., Wang Y., Zhang Y., Cui X., Yang Z., Chen Z. Lactoferrin: A glycoprotein that plays an active role in human health. Front. Nutr. 2023;9:1018336. doi: 10.3389/fnut.2022.1018336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.1018336</ArticleId><ArticleId IdType="pmc">PMC9875800</ArticleId><ArticleId IdType="pubmed">36712548</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Montoya I.A., Cendón T.S., Arévalo-Gallegos S., Rascón-Cruz Q. Lactoferrin a multiple bioactive protein: An overview. Biochim. Biophys. Acta (BBA) Gen. Subj. 2012;1820:226–236. doi: 10.1016/j.bbagen.2011.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2011.06.018</ArticleId><ArticleId IdType="pmc">PMC7127262</ArticleId><ArticleId IdType="pubmed">21726601</ArticleId></ArticleIdList></Reference><Reference><Citation>Siqueiros-Cendón T., Arévalo-Gallegos S., Iglesias-Figueroa B.F., García-Montoya I.A., Salazar-Martínez J., Rascón-Cruz Q. Immunomodulatory effects of lactoferrin. Acta Pharmacol. Sin. 2014;35:557–566. doi: 10.1038/aps.2013.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2013.200</ArticleId><ArticleId IdType="pmc">PMC4814036</ArticleId><ArticleId IdType="pubmed">24786230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeur S., Spahis S., Pouliot Y., Levy E. Lactoferrin, a pleiotropic protein in health and disease. Antioxid. Redox Signal. 2016;24:813–836. doi: 10.1089/ars.2015.6458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2015.6458</ArticleId><ArticleId IdType="pubmed">26981846</ArticleId></ArticleIdList></Reference><Reference><Citation>Actor J., Hwang S.-A., Kruzel M. Lactoferrin as a natural immune modulator. Curr. Pharm. Des. 2009;15:1956–1973. doi: 10.2174/138161209788453202.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161209788453202</ArticleId><ArticleId IdType="pmc">PMC2915836</ArticleId><ArticleId IdType="pubmed">19519436</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascón-Cruz Q., Espinoza-Sánchez E.A., Siqueiros-Cendón T.S., Nakamura-Bencomo S.I., Arévalo-Gallegos S., Iglesias-Figueroa B.F. Lactoferrin: A glycoprotein involved in immunomodulation, anticancer, and antimicrobial processes. Molecules. 2021;26:205. doi: 10.3390/molecules26010205.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26010205</ArticleId><ArticleId IdType="pmc">PMC7795860</ArticleId><ArticleId IdType="pubmed">33401580</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand D., Elass E., Carpentier M., Mazurier J. Lactoferrin: A modulator of immune and inflammatory responses. Cell. Mol. Life Sci. 2005;62:2549. doi: 10.1007/s00018-005-5370-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-005-5370-2</ArticleId><ArticleId IdType="pmc">PMC7079806</ArticleId><ArticleId IdType="pubmed">16261255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Heyden E.L., Pretorius E. The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria. Front. Immunol. 2020;11:1221. doi: 10.3389/fimmu.2020.01221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01221</ArticleId><ArticleId IdType="pmc">PMC7271924</ArticleId><ArticleId IdType="pubmed">32574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Francis J., Doster R.S., Haley K.P., Craft K.M., Moore R.E., Chambers S.A., Aronoff D.M., Osteen K., Damo S.M., et al. Lactoferrin: A critical mediator of both host immune response and antimicrobial activity in response to streptococcal infections. ACS Infect. Dis. 2020;6:1615–1623. doi: 10.1021/acsinfecdis.0c00050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00050</ArticleId><ArticleId IdType="pmc">PMC7354219</ArticleId><ArticleId IdType="pubmed">32329605</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarzosa-Moreno D., Avalos-Gómez C., Ramírez-Texcalco L.S., Torres-López E., Ramírez-Mondragón R., Hernández-Ramírez J.O., Serrano-Luna J., De La Garza M. Lactoferrin and its derived peptides: An alternative for combating virulence mechanisms developed by pathogens. Molecules. 2020;25:5763. doi: 10.3390/molecules25245763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25245763</ArticleId><ArticleId IdType="pmc">PMC7762604</ArticleId><ArticleId IdType="pubmed">33302377</ArticleId></ArticleIdList></Reference><Reference><Citation>Latorre D., Berlutti F., Valenti P., Gessani S., Puddu P. LF immunomodulatory strategies: Mastering bacterial endotoxin. Biochem. Cell Biol. 2012;90:269–278. doi: 10.1139/o11-059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/o11-059</ArticleId><ArticleId IdType="pubmed">22300429</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand D. Overview of lactoferrin as a natural immune modulator. J. Ped. 2016;173:S10–S15. doi: 10.1016/j.jpeds.2016.02.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2016.02.071</ArticleId><ArticleId IdType="pubmed">27234406</ArticleId></ArticleIdList></Reference><Reference><Citation>Artym J., Zimecki M., Kruzel M.L. Lactoferrin for prevention and treatment of anemia and inflammation in pregnant women: A comprehensive review. Biomedicines. 2021;9:898. doi: 10.3390/biomedicines9080898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080898</ArticleId><ArticleId IdType="pmc">PMC8389615</ArticleId><ArticleId IdType="pubmed">34440102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruzel M.L., Actor J.K., Zimecki M., Wise J., Płoszaj P., Mirza S., Kruzel M., Hwang S.-A., Ba X., Boldogh I. Novel recombinant human lactoferrin: Differential activation of oxidative stress related gene expression. J. Biotechnol. 2013;168:666–675. doi: 10.1016/j.jbiotec.2013.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiotec.2013.09.011</ArticleId><ArticleId IdType="pmc">PMC3987904</ArticleId><ArticleId IdType="pubmed">24070904</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlutti F., Pantanella F., Natalizi T., Frioni A., Paesano R., Polimeni A., Valenti P. Antiviral properties of lactoferrin—A natural immunity molecule. Molecules. 2011;16:6992–7018. doi: 10.3390/molecules16086992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules16086992</ArticleId><ArticleId IdType="pmc">PMC6264778</ArticleId><ArticleId IdType="pubmed">21847071</ArticleId></ArticleIdList></Reference><Reference><Citation>Maneva A., Taleva B., Maneva L. Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes. Z. Naturforschung C. 2003;58:256–262. doi: 10.1515/znc-2003-3-420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/znc-2003-3-420</ArticleId><ArticleId IdType="pubmed">12710738</ArticleId></ArticleIdList></Reference><Reference><Citation>Shini V.S., Udayarajan C.T., Nisha P. A comprehensive review on lactoferrin: A natural multifunctional glycoprotein. Food Funct. 2022;13:11954–11972. doi: 10.1039/D2FO02371G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2FO02371G</ArticleId><ArticleId IdType="pubmed">36383056</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Zhang B., Liu X., Zheng Y., Han K., Liu H., Wu C., Li J., Fan S., Peng W., et al. The effect of lactoferrin in aging: Role and potential. Food Funct. 2022;13:501–513. doi: 10.1039/D1FO02750F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1FO02750F</ArticleId><ArticleId IdType="pubmed">34928288</ArticleId></ArticleIdList></Reference><Reference><Citation>Giansanti F., Panella G., Leboffe L., Antonini G. Lactoferrin from milk: Nutraceutical and pharmacological properties. Pharmaceuticals. 2016;9:61. doi: 10.3390/ph9040061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph9040061</ArticleId><ArticleId IdType="pmc">PMC5198036</ArticleId><ArticleId IdType="pubmed">27690059</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputo V., Libera M., Sisti S., Giuliani B., Diotti R.A., Criscuolo E. The initial interplay between HIV and mucosal innate immunity. Front. Immunol. 2023;14:1104423. doi: 10.3389/fimmu.2023.1104423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1104423</ArticleId><ArticleId IdType="pmc">PMC9927018</ArticleId><ArticleId IdType="pubmed">36798134</ArticleId></ArticleIdList></Reference><Reference><Citation>Redwan E.M., Uversky V.N., El-Fakharany E.M., Al-Mehdar H. Potential lactoferrin activity against pathogenic viruses. Comptes Rendus Biol. 2014;337:581–595. doi: 10.1016/j.crvi.2014.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crvi.2014.08.003</ArticleId><ArticleId IdType="pubmed">25282173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang J., Yang N., Deng J., Liu K., Yang P., Zhang G., Jiang C. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS ONE. 2011;6:e23710. doi: 10.1371/journal.pone.0023710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023710</ArticleId><ArticleId IdType="pmc">PMC3161750</ArticleId><ArticleId IdType="pubmed">21887302</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenti P., Antonini G. Lactoferrin: An important host defence against microbial and viral attack. Cell Mol. Life Sci. 2005;62:2576–2587. doi: 10.1007/s00018-005-5372-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-005-5372-0</ArticleId><ArticleId IdType="pmc">PMC11139069</ArticleId><ArticleId IdType="pubmed">16261253</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Strate B.W.A., Beljaars L., Molema G., Harmsen M.C., Meijer D.K.F. Antiviral activities of lactoferrin. Antivir. Res. 2001;52:225–239. doi: 10.1016/S0166-3542(01)00195-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-3542(01)00195-4</ArticleId><ArticleId IdType="pubmed">11675140</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinopoli A., Isonne C., Santoro M.M., Baccolini V. The effects of orally administered lactoferrin in the prevention and management of viral infections: A systematic review. Rev. Med. Virol. 2022;32:e2261. doi: 10.1002/rmv.2261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2261</ArticleId><ArticleId IdType="pmc">PMC9286571</ArticleId><ArticleId IdType="pubmed">34133812</ArticleId></ArticleIdList></Reference><Reference><Citation>Salaris C., Scarpa M., Elli M., Bertolini A., Guglielmetti S., Pregliasco F., Blandizzi C., Brun P., Castagliuolo I. Protective effects of lactoferrin against SARS-CoV-2 infection in vitro. Nutrients. 2021;13:328. doi: 10.3390/nu13020328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020328</ArticleId><ArticleId IdType="pmc">PMC7911668</ArticleId><ArticleId IdType="pubmed">33498631</ArticleId></ArticleIdList></Reference><Reference><Citation>Drago-Serrano M., Campos-Rodríguez R., Carrero J., De La Garza M. Lactoferrin: Balancing ups and downs of inflammation due to microbial infections. Int. J. Mol. Sci. 2017;18:501. doi: 10.3390/ijms18030501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18030501</ArticleId><ArticleId IdType="pmc">PMC5372517</ArticleId><ArticleId IdType="pubmed">28257033</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi H., Oda H., Yamauchi K., Abe F. Lactoferrin for prevention of common viral infections. J. Infect. Chemother. 2014;20:666–671. doi: 10.1016/j.jiac.2014.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2014.08.003</ArticleId><ArticleId IdType="pubmed">25182867</ArticleId></ArticleIdList></Reference><Reference><Citation>Puddu P., Valenti P., Gessani S. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie. 2009;91:11–18. doi: 10.1016/j.biochi.2008.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2008.05.005</ArticleId><ArticleId IdType="pubmed">18539153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.S., Chen P.W. Featured prebiotic agent: The roles and mechanisms of direct and indirect prebiotic activities of lactoferrin and its application in disease control. Nutrients. 2023;15:2759. doi: 10.3390/nu15122759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15122759</ArticleId><ArticleId IdType="pmc">PMC10304695</ArticleId><ArticleId IdType="pubmed">37375663</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenti P., Rosa L., Capobianco D., Lepanto M.S., Schiavi E., Cutone A., Paesano R., Mastromarino P. Role of lactobacilli and lactoferrin in the mucosal cervicovaginal defense. Front. Immunol. 2018;9:376. doi: 10.3389/fimmu.2018.00376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00376</ArticleId><ArticleId IdType="pmc">PMC5837981</ArticleId><ArticleId IdType="pubmed">29545798</ArticleId></ArticleIdList></Reference><Reference><Citation>Santacroce L., Palmirotta R., Bottalico L., Charitos I.A., Colella M., Topi S., Jirillo E. Crosstalk between the resident microbiota and the immune cells regulates female genital tract health. Life. 2023;13:1531. doi: 10.3390/life13071531.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13071531</ArticleId><ArticleId IdType="pmc">PMC10381428</ArticleId><ArticleId IdType="pubmed">37511906</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega-Bautista A., de la Garza M., Carrero J.C., Campos-Rodríguez R., Godínez-Victoria M., Drago-Serrano M.E. The impact of lactoferrin on the growth of intestinal inhabitant bacteria. Int. J. Mol. Sci. 2019;20:4707. doi: 10.3390/ijms20194707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20194707</ArticleId><ArticleId IdType="pmc">PMC6801499</ArticleId><ArticleId IdType="pubmed">31547574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wotring J.W., Fursmidt R., Ward L., Sexton J.Z. Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern. J. Dairy Sci. 2022;105:2791–2802. doi: 10.3168/jds.2021-21247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3168/jds.2021-21247</ArticleId><ArticleId IdType="pmc">PMC8872794</ArticleId><ArticleId IdType="pubmed">35221061</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Meng X., Zhang F., Xiang Y., Wang J. The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg. Microbes Infect. 2021;10:317–330. doi: 10.1080/22221751.2021.1888660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1888660</ArticleId><ArticleId IdType="pmc">PMC7919907</ArticleId><ArticleId IdType="pubmed">33560940</ArticleId></ArticleIdList></Reference><Reference><Citation>Miotto M., Di Rienzo L., Bò L., Boffi A., Ruocco G., Milanetti E. Molecular mechanisms behind anti SARS-CoV-2 action of lactoferrin. Front. Mol. Biosci. 2021;8:607443. doi: 10.3389/fmolb.2021.607443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.607443</ArticleId><ArticleId IdType="pmc">PMC7917183</ArticleId><ArticleId IdType="pubmed">33659275</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa L., Cutone A., Conte M.P., Campione E., Bianchi L., Valenti P. An overview on in vitro and in vivo antiviral activity of lactoferrin: Its efficacy against SARS-CoV-2 infection. Biometals. 2023;36:417–436. doi: 10.1007/s10534-022-00427-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-022-00427-z</ArticleId><ArticleId IdType="pmc">PMC9362590</ArticleId><ArticleId IdType="pubmed">35920949</ArticleId></ArticleIdList></Reference><Reference><Citation>Piacentini R., Centi L., Miotto M., Milanetti E., Di Rienzo L., Pitea M., Piazza P., Ruocco G., Boffi A., Parisi G. Lactoferrin inhibition of the complex formation between ACE2 receptor and SARS CoV-2 recognition binding domain. Int. J. Mol. Sci. 2022;23:5436. doi: 10.3390/ijms23105436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23105436</ArticleId><ArticleId IdType="pmc">PMC9141661</ArticleId><ArticleId IdType="pubmed">35628247</ArticleId></ArticleIdList></Reference><Reference><Citation>Einerhand A.W.C., Van Loo-Bouwman C.A., Weiss G.A., Wang C., Ba G., Fan Q., He B., Smit G. Can lactoferrin, a natural mammalian milk protein, assist in the battle against COVID-19? Nutrients. 2022;14:5274. doi: 10.3390/nu14245274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14245274</ArticleId><ArticleId IdType="pmc">PMC9782828</ArticleId><ArticleId IdType="pubmed">36558432</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib H.M., Ibrahim S., Zaim A., Ibrahim W.H. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed. Pharmacother. 2021;136:111228. doi: 10.1016/j.biopha.2021.111228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111228</ArticleId><ArticleId IdType="pmc">PMC7836924</ArticleId><ArticleId IdType="pubmed">33454595</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione E., Lanna C., Cosio T., Rosa L., Conte M.P., Iacovelli F., Romeo A., Falconi M., Del Vecchio C., Franchin E., et al. Lactoferrin as antiviral treatment in COVID-19 management: Preliminary evidence. Int. J. Environ. Res. Public Health. 2021;18:10985. doi: 10.3390/ijerph182010985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182010985</ArticleId><ArticleId IdType="pmc">PMC8535893</ArticleId><ArticleId IdType="pubmed">34682731</ArticleId></ArticleIdList></Reference><Reference><Citation>Algahtani F.D., Elabbasy M.T., Samak M.A., Adeboye A.A., Yusuf R.A., Ghoniem M.E. The prospect of lactoferrin use as adjunctive agent in management of SARS-CoV-2 patients: A randomized pilot study. Medicina. 2021;57:842. doi: 10.3390/medicina57080842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57080842</ArticleId><ArticleId IdType="pmc">PMC8401801</ArticleId><ArticleId IdType="pubmed">34441048</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano G., Kochergina I., Albors A., Diaz E., Oroval M., Hueso G., Serrano J.M. Liposomal lactoferrin as potential preventative and cure for COVID-19. Int. J. Res. Health Sci. 2020;8:8–15. doi: 10.5530/ijrhs.8.1.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.5530/ijrhs.8.1.3</ArticleId></ArticleIdList></Reference><Reference><Citation>Matino E., Tavella E., Rizzi M., Avanzi G.C., Azzolina D., Battaglia A., Becco P., Bellan M., Bertinieri G., Bertoletti M., et al. Effect of lactoferrin on clinical outcomes of hospitalized patients with COVID-19: The LAC randomized clinical trial. Nutrients. 2023;15:1285. doi: 10.3390/nu15051285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15051285</ArticleId><ArticleId IdType="pmc">PMC10005739</ArticleId><ArticleId IdType="pubmed">36904283</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa L., Lepanto M.S., Cutone A., Siciliano R.A., Paesano R., Costi R., Musci G., Valenti P. Influence of oral administration mode on the efficacy of commercial bovine lactoferrin against iron and inflammatory homeostasis disorders. Biometals. 2020;33:159–168. doi: 10.1007/s10534-020-00236-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-020-00236-2</ArticleId><ArticleId IdType="pubmed">32274616</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Timilsena Y.P., Blanch E., Adhikari B. Lactoferrin: Structure, function, denaturation and digestion. Crit. Rev. Food Sci. Nutr. 2019;59:580–596. doi: 10.1080/10408398.2017.1381583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2017.1381583</ArticleId><ArticleId IdType="pubmed">28933602</ArticleId></ArticleIdList></Reference><Reference><Citation>Dix C., Wright O. Bioavailability of a novel form of microencapsulated bovine lactoferrin and its effect on inflammatory markers and the gut microbiome: A pilot study. Nutrients. 2018;10:1115. doi: 10.3390/nu10081115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10081115</ArticleId><ArticleId IdType="pmc">PMC6115941</ArticleId><ArticleId IdType="pubmed">30126153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikado A., Imanaka H., Kotani M., Fujita A., Mitsuishi Y., Kanemitsu T., Tamura Y., Makino T. Liposomal lactoferrin induced significant increase of the interferon-alpha (IFN-α) producibility in healthy volunteers. BioFactors. 2004;21:69–72. doi: 10.1002/biof.552210113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.552210113</ArticleId><ArticleId IdType="pubmed">15630172</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang R., Lopez V., Kelleher S.L., Lönnerdal B. Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells. J. Cell Physiol. 2011;226:3022–3031. doi: 10.1002/jcp.22650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22650</ArticleId><ArticleId IdType="pmc">PMC3178039</ArticleId><ArticleId IdType="pubmed">21935933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrackmeyer U., Hansen G.H., Seya T., Danielsen E.M. Intelectin: A novel lipid raft-associated protein in the enterocyte brush border. Biochemistry. 2006;45:9188–9197. doi: 10.1021/bi060570x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi060570x</ArticleId><ArticleId IdType="pubmed">16866365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashida K., Sasaki H., Suzuki Y.A., Lönnerdal B. Cellular internalization of lactoferrin in intestinal epithelial cells. Biometals. 2004;17:311–315. doi: 10.1023/B:BIOM.0000027710.13543.3f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:BIOM.0000027710.13543.3f</ArticleId><ArticleId IdType="pubmed">15222483</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Ramya T.N.C. Saccharide binding by intelectins. Int. J. Biol. Macromol. 2018;108:1010–1016. doi: 10.1016/j.ijbiomac.2017.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2017.11.007</ArticleId><ArticleId IdType="pubmed">29113893</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima Y., Seki K., Shibuya M., Naka Y., Yokoyama T., Sato A. Soluble human intestinal lactoferrin receptor: Ca2+-dependent binding to sepharose-based matrices. Biol. Pharm. Bull. 2016;39:435–439. doi: 10.1248/bpb.b15-00643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b15-00643</ArticleId><ArticleId IdType="pubmed">26934934</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama Y., Oshima K., Kuhara T., Shin K., Abe F., Iwatsuki K., Nadano D., Matsuda T. A lactoferrin-receptor, intelectin 1, affects uptake, subcellular localization and release of immunochemically detectable lactoferrin by intestinal epithelial Caco-2 cells. J. Biochem. 2013;154:437–448. doi: 10.1093/jb/mvt073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvt073</ArticleId><ArticleId IdType="pubmed">23921499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lönnerdal B. Infant formula and infant nutrition: Bioactive proteins of human milk and implications for composition of infant formulas. Am. J. Clin. Nutr. 2014;99:712S. doi: 10.3945/ajcn.113.071993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.113.071993</ArticleId><ArticleId IdType="pubmed">24452231</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y.A., Lopez V., Lönnerdal B. Mammalian lactoferrin receptors: Structure and function. Cell Mol. Life Sci. 2005;62:2560–2575. doi: 10.1007/s00018-005-5371-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-005-5371-1</ArticleId><ArticleId IdType="pmc">PMC11139119</ArticleId><ArticleId IdType="pubmed">16261254</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi T., Kitagawa H., Harada E. Evidence of lactoferrin transportation into blood circulation from intestine via lymphatic pathway in adult rats. Exp. Physiol. 2004;89:263–270. doi: 10.1113/expphysiol.2003.026633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2003.026633</ArticleId><ArticleId IdType="pubmed">15123561</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansems K., Grundeis F., Dahms K., Mikolajewska A., Thieme V., Piechotta V., Metzendorf M.-I., Stegemann M., Benstoem C., Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst. Rev. 2021;8:CD014962. doi: 10.1002/14651858.CD014962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD014962</ArticleId><ArticleId IdType="pmc">PMC8406992</ArticleId><ArticleId IdType="pubmed">34350582</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb R.L., Vaca C.E., Paredes R., Mera J., Webb B.J., Perez G., Oguchi G., Ryan P., Nielsen B.U., Brown M., et al. Early remdesivir to prevent progression to severe COVID-19 in outpatients. N. Engl. J. Med. 2022;386:305–315. doi: 10.1056/NEJMoa2116846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116846</ArticleId><ArticleId IdType="pmc">PMC8757570</ArticleId><ArticleId IdType="pubmed">34937145</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams D.M. Clinical pharmacology of corticosteroids. Respir. Care. 2018;63:655–670. doi: 10.4187/respcare.06314.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.06314</ArticleId><ArticleId IdType="pubmed">29794202</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes P.J. How corticosteroids control inflammation: Quintiles Prize Lecture. Br. J. Pharmacol. 2006;148:245–254. doi: 10.1038/sj.bjp.0706736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0706736</ArticleId><ArticleId IdType="pmc">PMC1751559</ArticleId><ArticleId IdType="pubmed">16604091</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Raya B., Michalski C., Sadarangani M., Lavoie P.M. Maternal immunological adaptation during normal pregnancy. Front. Immunol. 2020;11:575197. doi: 10.3389/fimmu.2020.575197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.575197</ArticleId><ArticleId IdType="pmc">PMC7579415</ArticleId><ArticleId IdType="pubmed">33133091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourtis A.P., Read J.S., Jamieson D.J. Pregnancy and infection. N. Engl. J. Med. 2014;370:2211–2218. doi: 10.1056/NEJMra1213566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1213566</ArticleId><ArticleId IdType="pmc">PMC4459512</ArticleId><ArticleId IdType="pubmed">24897084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.P., Tan G.C., Khong T.Y. SARS-CoV-2 transplacental transmission: A rare occurrence? An overview of the protective role of the placenta. Int. J. Mol. Sci. 2023;24:4550. doi: 10.3390/ijms24054550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054550</ArticleId><ArticleId IdType="pmc">PMC10002996</ArticleId><ArticleId IdType="pubmed">36901979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wai J.Y., Wood E.M., Hornaday K.K., Slater D.M. Potential molecular and cellular mechanisms for adverse placental outcomes in pregnancies complicated by SARS-CoV-2 infection—A scoping review. PLoS ONE. 2023;18:e0283453. doi: 10.1371/journal.pone.0283453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0283453</ArticleId><ArticleId IdType="pmc">PMC10035918</ArticleId><ArticleId IdType="pubmed">36952548</ArticleId></ArticleIdList></Reference><Reference><Citation>Giunta G., Giuffrida L., Mangano K., Fagone P., Cianci A. Influence of lactoferrin in preventing preterm delivery: A pilot study. Mol. Med. Rep. 2012;5:162–166. doi: 10.3892/mmr.2011.584.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2011.584</ArticleId><ArticleId IdType="pubmed">21922138</ArticleId></ArticleIdList></Reference><Reference><Citation>Pino A., Giunta G., Randazzo C.L., Caruso S., Caggia C., Cianci A. Bacterial biota of women with bacterial vaginosis treated with lactoferrin: An open prospective randomized trial. Microb. Ecol. Health Dis. 2017;28:1357417. doi: 10.1080/16512235.2017.1357417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16512235.2017.1357417</ArticleId><ArticleId IdType="pmc">PMC5614382</ArticleId><ArticleId IdType="pubmed">28959181</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomorski M., Trzeszcz M., Matera-Witkiewicz A., Krupińska M., Fuchs T., Zimmer M., Zimmer-Stelmach A., Rosner-Tenerowicz A., Budny-Wińska J., Tarczyńska-Podraza A., et al. SARS-CoV-2 infection and pregnancy: Maternal and neonatal outcomes and placental pathology correlations. Viruses. 2022;14:2043. doi: 10.3390/v14092043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14092043</ArticleId><ArticleId IdType="pmc">PMC9503119</ArticleId><ArticleId IdType="pubmed">36146849</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukowska-Ośko I., Popiel M., Kowalczyk P. The immunological role of the placenta in SARS-CoV-2 infection-viral transmission, immune regulation, and lactoferrin activity. Int. J. Mol. Sci. 2021;22:5799. doi: 10.3390/ijms22115799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115799</ArticleId><ArticleId IdType="pmc">PMC8198160</ArticleId><ArticleId IdType="pubmed">34071527</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu S.A.G., Clemens R.A., Pressman P., Zaigham M., Davies K.J.A., Naidu A.S. COVID-19 during pregnancy and postpartum. J. Diet. Suppl. 2022;19:78–114. doi: 10.1080/19390211.2020.1834047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2020.1834047</ArticleId><ArticleId IdType="pubmed">33164606</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Girolamo R., Khalil A., Alameddine S., D’Angelo E., Galliani C., Matarrelli B., Buca D., Liberati M., Rizzo G., D’Antonio F. Placental histopathology after SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. MFM. 2021;3:100468. doi: 10.1016/j.ajogmf.2021.100468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2021.100468</ArticleId><ArticleId IdType="pmc">PMC8379009</ArticleId><ArticleId IdType="pubmed">34425296</ArticleId></ArticleIdList></Reference><Reference><Citation>Azinheira Nobrega Cruz N., Stoll D., Casarini D.E., Bertagnolli M. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility. Clin. Sci. 2021;135:1805–1824. doi: 10.1042/CS20210284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20210284</ArticleId><ArticleId IdType="pmc">PMC8329853</ArticleId><ArticleId IdType="pubmed">34338772</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Gu Y., Lewis D.F., Gu X., Brown K., Lachute C., Hankins M., Scott R.S., Busada C., Cooper D.B., et al. Cell-type specific distribution and activation of type I IFN pathway molecules at the placental maternal-fetal interface in response to COVID-19 infection. Front. Endocrinol. 2023;13:951388. doi: 10.3389/fendo.2022.951388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.951388</ArticleId><ArticleId IdType="pmc">PMC9895786</ArticleId><ArticleId IdType="pubmed">36743911</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebutini P.Z., Zanchettin A.C., Stonoga E.T.S., Prá D.M.M., de Oliveira A.L.P., da Silva Dezidério F., Fonseca A.S., Dagostini J.C.H., Hlatchuk E.C., Furuie I.N., et al. Association between COVID-19 pregnant women symptoms severity and placental morphologic features. Front. Immunol. 2021;12:685919. doi: 10.3389/fimmu.2021.685919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.685919</ArticleId><ArticleId IdType="pmc">PMC8187864</ArticleId><ArticleId IdType="pubmed">34122449</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanes E.D., Mithal L.B., Otero S., Azad H.A., Miller E.S., Goldstein J.A. Placental pathology in COVID-19. Am. J. Clin. Pathol. 2020;154:23–32. doi: 10.1093/ajcp/aqaa089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa089</ArticleId><ArticleId IdType="pmc">PMC7279066</ArticleId><ArticleId IdType="pubmed">32441303</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca D., Vauloup-Fellous C., Benachi A., Vivanti A. Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do? Semin. Fetal Neonatal Med. 2023;28:101429. doi: 10.1016/j.siny.2023.101429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.siny.2023.101429</ArticleId><ArticleId IdType="pmc">PMC10010052</ArticleId><ArticleId IdType="pubmed">36935314</ArticleId></ArticleIdList></Reference><Reference><Citation>Moza A., Duica F., Antoniadis P., Bernad E.S., Lungeanu D., Craina M., Bernad B.C., Paul C., Muresan C., Nitu R., et al. Outcome of newborns with confirmed or possible SARS-CoV-2 vertical infection—A scoping review. Diagnostics. 2023;13:245. doi: 10.3390/diagnostics13020245.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13020245</ArticleId><ArticleId IdType="pmc">PMC9858608</ArticleId><ArticleId IdType="pubmed">36673058</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzi M., Patrucco F., Trevisan M., Faolotto G., Mercandino A., Strola C., Ravanini P., Costanzo M., Tonello S., Matino E., et al. Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients. Panminerva Med. 2022;64:465–471. doi: 10.23736/S0031-0808.22.04705-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0031-0808.22.04705-X</ArticleId><ArticleId IdType="pubmed">35713624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirbeyk M., Saghazadeh A., Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch. Gynecol. Obstet. 2021;304:5–38. doi: 10.1007/s00404-021-06049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-021-06049-z</ArticleId><ArticleId IdType="pmc">PMC8017514</ArticleId><ArticleId IdType="pubmed">33797605</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano L.D., Ellington S., Strid P., Galang R.R., Oduyebo T., Tong V.T., Woodworth K.R., Nahabedian J.F., III, Azziz-Baumgartner E., Gilboa S.M., et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–October 3. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1641–1647. doi: 10.15585/mmwr.mm6944e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6944e3</ArticleId><ArticleId IdType="pmc">PMC7643892</ArticleId><ArticleId IdType="pubmed">33151921</ArticleId></ArticleIdList></Reference><Reference><Citation>Badr D.A., Mattern J., Carlin A., Cordier A.-G., Maillart E., El Hachem L., El Kenz H., Andronikof M., De Bels D., Damoisel C., et al. Are clinical outcomes worse for pregnant women at ≥20 weeks’ gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching. Am. J. Obstet. Gynecol. 2020;223:764–768. doi: 10.1016/j.ajog.2020.07.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.07.045</ArticleId><ArticleId IdType="pmc">PMC7384420</ArticleId><ArticleId IdType="pubmed">32730899</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuki K., Nishi T., Kondo T., Okubo K. Review, role of lactoferrin in preventing preterm delivery. Biometals. 2023;36:521–530. doi: 10.1007/s10534-022-00471-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-022-00471-9</ArticleId><ArticleId IdType="pmc">PMC10182139</ArticleId><ArticleId IdType="pubmed">36495415</ArticleId></ArticleIdList></Reference><Reference><Citation>Artym J., Zimecki M. Antimicrobial and prebiotic activity of lactoferrin in the female reproductive tract: A comprehensive review. Biomedicines. 2021;9:1940. doi: 10.3390/biomedicines9121940.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9121940</ArticleId><ArticleId IdType="pmc">PMC8699013</ArticleId><ArticleId IdType="pubmed">34944756</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuki K., Yoda A., Saito H., Mitsuhashi Y., Toma Y., Shimizu Y., Yanaihara T. Amniotic fluid lactoferrin in intrauterine infection. Placenta. 1999;20:175–179. doi: 10.1053/plac.1998.0368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/plac.1998.0368</ArticleId><ArticleId IdType="pubmed">10195738</ArticleId></ArticleIdList></Reference><Reference><Citation>Heller K.A., Greig P.C., Heine R.P. Amniotic-fluid lactoferrin: A marker for subclinical intraamniotic infection prior to 32 weeks gestation. Infect. Dis. Obstet. Gynecol. 1995;3:179–183. doi: 10.1155/S1064744995000573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/S1064744995000573</ArticleId><ArticleId IdType="pmc">PMC2366152</ArticleId><ArticleId IdType="pubmed">18472887</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulbis B., Jauniaux E., Decuyper J., Thiry P., Jurkovic D., Campbell S. Distribution of iron and iron-binding proteins in first-trimester human pregnancies. Obstet. Gynecol. 1994;84:289–293.</Citation><ArticleIdList><ArticleId IdType="pubmed">8041549</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawel P., Krolak-Olejnik B. Lactoferrin supplementation during pregnancy—A review of the literature and current recommendations. Ginekol. Pol. 2023;94:570–580. doi: 10.5603/GP.a2023.0020.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/GP.a2023.0020</ArticleId><ArticleId IdType="pubmed">36929803</ArticleId></ArticleIdList></Reference><Reference><Citation>Galderisi A., Lista G., Cavigioli F., Trevisanuto D. Clinical features of neonatal COVID-19. Semin. Fetal Neonatal Med. 2023;28:101430. doi: 10.1016/j.siny.2023.101430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.siny.2023.101430</ArticleId><ArticleId IdType="pmc">PMC10036147</ArticleId><ArticleId IdType="pubmed">37005209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan L., Plötz F.B., Hoogen A.v.D., Latour J.M., Degtyareva M., Keuning M., Klingenberg C., Reiss I.K.M., Giannoni E., Roehr C., et al. Neonates and COVID-19: State of the art: Neonatal sepsis series. Pediatr. Res. 2022;91:432–439. doi: 10.1038/s41390-021-01875-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-021-01875-y</ArticleId><ArticleId IdType="pmc">PMC8712275</ArticleId><ArticleId IdType="pubmed">34961785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers C., Krogstad P., Bertrand K., Contreras D., Tobin N.H., Bode L., Aldrovandi G. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA. 2020;324:1347–1348. doi: 10.1001/jama.2020.15580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.15580</ArticleId><ArticleId IdType="pmc">PMC7439212</ArticleId><ArticleId IdType="pubmed">32822495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesołowska A., Orczyk-Pawiłowicz M., Bzikowska-Jura A., Gawrońska M., Walczak B. Protecting breastfeeding during the COVID-19 pandemic: A scoping review of perinatal care recommendations in the context of maternal and child well-being. Int. J. Environ. Res. Public Health. 2022;19:3347. doi: 10.3390/ijerph19063347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19063347</ArticleId><ArticleId IdType="pmc">PMC8949921</ArticleId><ArticleId IdType="pubmed">35329035</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatz D.L., Davanzo R., Müller J.A., Powell R., Rigourd V., Yates A., Geddes D.T., Van Goudoever J.B., Bode L. Promoting and protecting human milk and breastfeeding in a COVID-19 world. Front. Pediatr. 2021;8:633700. doi: 10.3389/fped.2020.633700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.633700</ArticleId><ArticleId IdType="pmc">PMC7888272</ArticleId><ArticleId IdType="pubmed">33614547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankar M.J., Sinha B., Chowdhury R., Bhandari N., Taneja S., Martines J., Bahl R. Optimal breastfeeding practices and infant and child mortality: A systematic review and meta-analysis. Acta Paediatr. 2015;104:3–13. doi: 10.1111/apa.13147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.13147</ArticleId><ArticleId IdType="pubmed">26249674</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A. Breast milk as the gold standard for protective nutrients. J. Ped. 2010;156:S3–S7. doi: 10.1016/j.jpeds.2009.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2009.11.021</ArticleId><ArticleId IdType="pubmed">20105662</ArticleId></ArticleIdList></Reference><Reference><Citation>Briana D.D., Papadopoulou A., Syridou G., Marchisio E., Kapsabeli E., Daskalaki A., Papaevangelou V. Early human milk lactoferrin during SARS-CoV-2 infection. J. Matern.-Fetal Neonatal Med. 2022;35:6704–6707. doi: 10.1080/14767058.2021.1920010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2021.1920010</ArticleId><ArticleId IdType="pubmed">33969775</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Filho P.R., Santos V.S., Santos H.P. To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19. Rev. Panamer. Salud Públ. 2020;44:e59. doi: 10.26633/RPSP.2020.59.</Citation><ArticleIdList><ArticleId IdType="doi">10.26633/RPSP.2020.59</ArticleId><ArticleId IdType="pmc">PMC7241574</ArticleId><ArticleId IdType="pubmed">32454808</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguila Altoé A., Marques Mambriz A.P., Cardozo D.M., Valentini Zacarias J.M., Laguila Visentainer J.E., Bahls-Pinto L.D. Vaccine protection through placenta and breastfeeding: The unmet topic in COVID-19 pandemic. Front. Immunol. 2022;13:910138. doi: 10.3389/fimmu.2022.910138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.910138</ArticleId><ArticleId IdType="pmc">PMC9203883</ArticleId><ArticleId IdType="pubmed">35720385</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassilopoulou E., Feketea G., Koumbi L., Mesiari C., Berghea E.C., Konstantinou G.N. Breastfeeding and COVID-19: From nutrition to immunity. Front. Immunol. 2021;12:661806. doi: 10.3389/fimmu.2021.661806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.661806</ArticleId><ArticleId IdType="pmc">PMC8058436</ArticleId><ArticleId IdType="pubmed">33897707</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y.F., Liu J.Q., Hu X.D., Li H.M., Wu N., Wang J., Jiang Z.G. Breastfeeding vs. breast milk transmission during COVID-19 pandemic, which is more important? Front. Pediatr. 2023;11:1253333. doi: 10.3389/fped.2023.1253333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1253333</ArticleId><ArticleId IdType="pmc">PMC10511770</ArticleId><ArticleId IdType="pubmed">37744448</ArticleId></ArticleIdList></Reference><Reference><Citation>Golan Y., Ilala M., Li L., Gay C., Hunagund S., Lin C.Y., Cassidy A.G., Jigmeddagva U., Matsui Y., Ozarslan N., et al. Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection. iScience. 2023;26:107767. doi: 10.1016/j.isci.2023.107767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107767</ArticleId><ArticleId IdType="pmc">PMC10507209</ArticleId><ArticleId IdType="pubmed">37731614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatmal M.M., Al-Hatamleh M.A.I., Olaimat A.N., Alshaer W., Hasan H., Albakri K.A., Alkhafaji E., Issa N.N., Al-Holy M.A., Abderrahman S.M., et al. Immunomodulatory properties of human breast milk: microRNA contents and potential epigenetic effects. Biomedicines. 2022;10:1219. doi: 10.3390/biomedicines10061219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10061219</ArticleId><ArticleId IdType="pmc">PMC9219990</ArticleId><ArticleId IdType="pubmed">35740242</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Lozano E., Sebastián-Valles F., Knott-Torcal C. Circulating microRNAs in breast milk and their potential impact on the infant. Nutrients. 2020;12:3066. doi: 10.3390/nu12103066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12103066</ArticleId><ArticleId IdType="pmc">PMC7601398</ArticleId><ArticleId IdType="pubmed">33049923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalczyk P., Kaczyńska K., Kleczkowska P., Bukowska-Ośko I., Kramkowski K., Sulejczak D. The lactoferrin phenomenon—A miracle molecule. Molecules. 2022;27:2941. doi: 10.3390/molecules27092941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092941</ArticleId><ArticleId IdType="pmc">PMC9104648</ArticleId><ArticleId IdType="pubmed">35566292</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruden Š., Poklar Ulrih N. Diverse mechanisms of antimicrobial activities of lactoferrins, lactoferricins, and other lactoferrin-derived peptides. Int. J. Mol. Sci. 2021;22:11264. doi: 10.3390/ijms222011264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222011264</ArticleId><ArticleId IdType="pmc">PMC8541349</ArticleId><ArticleId IdType="pubmed">34681923</ArticleId></ArticleIdList></Reference><Reference><Citation>Czosnykowska-Łukacka M., Orczyk-Pawiłowicz M., Broers B., Królak-Olejnik B. Lactoferrin in human milk of prolonged lactation. Nutrients. 2019;11:2350. doi: 10.3390/nu11102350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11102350</ArticleId><ArticleId IdType="pmc">PMC6835443</ArticleId><ArticleId IdType="pubmed">31581741</ArticleId></ArticleIdList></Reference><Reference><Citation>Raic D., Adelman A.S., Zhuang W., Rai G.P., Boettcher J., Lönnerdal B. Longitudinal changes in lactoferrin concentrations in human milk: A global systematic review. Crit. Rev. Food Sci. Nutr. 2014;54:1539–1547. doi: 10.1080/10408398.2011.642422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2011.642422</ArticleId><ArticleId IdType="pubmed">24580556</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodman T., Strunk T., Patole S., Hartmann B., Simmer K., Currie A. Effects of lactoferrin on neonatal pathogens and bifidobacterium breve in human breast milk. PLoS ONE. 2018;13:e0201819. doi: 10.1371/journal.pone.0201819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0201819</ArticleId><ArticleId IdType="pmc">PMC6104981</ArticleId><ArticleId IdType="pubmed">30133470</ArticleId></ArticleIdList></Reference><Reference><Citation>Lönnerdal B. Bioactive proteins in human milk: Health, nutrition, and implications for infant formulas. J. Ped. 2016;173:S4–S9. doi: 10.1016/j.jpeds.2016.02.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2016.02.070</ArticleId><ArticleId IdType="pubmed">27234410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa T.J., Chea-Woo E., Campos M., Pecho I., Prada A., McMahon R.J., Cleary T.G. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin. Infect. Dis. 2008;46:1881–1883. doi: 10.1086/588476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/588476</ArticleId><ArticleId IdType="pmc">PMC2440650</ArticleId><ArticleId IdType="pubmed">18462105</ArticleId></ArticleIdList></Reference><Reference><Citation>King J.C., Cummings G.E., Guo N., Trivedi L., Readmond B.X., Keane V., Feigelman S., Waard R.D. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J. Pediatr. Gastroenterol. Nutr. 2007;44:245–251. doi: 10.1097/01.mpg.0000243435.54958.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mpg.0000243435.54958.68</ArticleId><ArticleId IdType="pubmed">17255839</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin I., Atasay B., Dogu F., Okulu E., Arsan S., Karatas H., Ikinciogullari A., Turmen T. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. Am. J. Perinatol. 2014;31:1111–1120. doi: 10.1055/s-0034-1371704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1371704</ArticleId><ArticleId IdType="pubmed">24839144</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Liu B., Lin Y., Xue P., Lu Y., Song S., Li Y., Szeto I.M., Ren F., Guo H. The application of lactoferrin in infant formula: The past, present and future. Crit. Rev. Food Sci. Nutr. 2024;64:5748–5767. doi: 10.1080/10408398.2022.2157792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2022.2157792</ArticleId><ArticleId IdType="pubmed">36533432</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaweł P., Łukianowski B., Kościelska-Kasprzak K., Bartoszek D., Krajewska M., Królak-Olejnik B. Colostrum lactoferrin following active and recovered SARS-CoV-2 infections during pregnancy. Biomedicines. 2024;12:1120. doi: 10.3390/biomedicines12051120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12051120</ArticleId><ArticleId IdType="pmc">PMC11118264</ArticleId><ArticleId IdType="pubmed">38791082</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai X., Yu Y., Xian W., Ye F., Ju X., Luo Y., Dong H., Zhou Y.H., Tan W., Zhuang H., et al. Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication. iScience. 2022;25:104136. doi: 10.1016/j.isci.2022.104136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104136</ArticleId><ArticleId IdType="pmc">PMC8937612</ArticleId><ArticleId IdType="pubmed">35342878</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>